TITLE

Expanding the Universe of Discourse: The Cervical Cancer Vaccine

AUTHOR(S)
Kodish, Slavica
PUB. DATE
March 2011
SOURCE
Florida Communication Journal;Spring2011, Vol. 39 Issue 1, p29
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A recent study published in the prestigious medical journal Lancet attests to the effectiveness of the cervical cancer vaccine. Side effects of the vaccine are minimal, and the benefits highly promising, write the authors of the study. is the cervical cancer vaccine truly a wonderful medical breakthrough? Can inoculated women rely on the vaccine to protect them against developing cervical cancer? The answers ,nay not be encouraging as can be concluded from the study. in this paper, the author applies Nelson's (1995, 1996, 2001) concept of a counterstory to present a more complete account of the cervical cancer vaccine and, consequently, expand the universe of discourse.
ACCESSION #
63149311

 

Related Articles

  • A vaccine against cervical cancer.  // Discover;Jul96, Vol. 17 Issue 7, p22 

    Reports on the development of a vaccine against cervical cancer. Vaccine's use proteins; Effectiveness of the vaccine.

  • Kenya first country to protect girls against cervical cancer with GAVI support.  // Africa Health;May2013, Vol. 35 Issue 4, p11 

    The article reports that Kenya has become the first country to protect girls against cervical cancer with GAVI-supported human papillomavirus (HPV) vaccines.

  • Untitled. Dreisbach, Shaun // Parenting School Years;Aug2010, Vol. 24 Issue 7, p48 

    The article answers a question on whether an 11-year-old girl needs the vaccine for preventing cervical cancer.

  • Cervarix PI updated.  // Australian Journal of Pharmacy;Aug2011, Vol. 92 Issue 1095, p48 

    The article offers information on the product information (PI) of the Cervarix human papillomavirus (HPV) vaccine, which was shown as highly effective against cervical pre-cancerous lesions caused by HPV types 16 and 18.

  • Cervical cancer vaccination cost effective in Japan.  // PharmacoEconomics & Outcomes News;5/15/2010, Issue 603, p3 

    The article offers information on a Markov model, which indicated that cervical cancer vaccination in Japan may be cost-effective.

  • The proven way to protect your daughter from cancer. K. T. // Redbook;Mar2013, Vol. 220 Issue 3, p80 

    The article informs that a study has proved that vaccines help in preventing cervical cancer in teenage girls.

  • Bye bye pap tests?  // Herizons;Fall98, Vol. 12 Issue 3, p11 

    Reports that drugs company Merck and Co. is developing a vaccine to prevent cervical cancer. Human papilloma virus (HPV) as cause of the cancer.

  • One dose of HPV vaccine protected against cervical cancer for 4 years.  // Infectious Disease News;Dec2013, Vol. 26 Issue 12, p31 

    The article reports that a single dose of the human papillomavirus (HPV) 16/18 vaccine provided a durable antibody response against cervical cancer for 4 years, according to a study by author Mahboobeh Safaeian and colleagues, published in a 2013 issue of the "Cancer Prevention Research" journal.

  • Public perception A significant challenge in the battle against HPV. Rosberger, Zeev; Perez, Samara; King, Leonora; Franco, Eduardo L. // Oncology Exchange;May2013, Vol. 12 Issue 2, p16 

    HPV accounts for 5.2% of the worldwide cancer burden, including all cervical cancers, 50% of penile cancers and 88% of anal cancers. Two vaccines have recently been developed and licensed to target specific oncogenic and non-oncogenic types of HPV. In 2006, the Canadian government supported a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics